Back to Results
First PageMeta Content
Economics / Crime / Insider trading / Eli Lilly and Company / ImClone Systems / Samuel D. Waksal / SEC Rule 10b-5 / Cetuximab / Securities fraud / Corporate crime / Business / Corruption


Approved: ________________________________ MICHAEL S. SCHACHTER Assistant United States Attorney
Add to Reading List

Document Date: 2010-02-04 21:15:58


Open Document

File Size: 147,00 KB

Share Result on Facebook

City

New York / /

Company

Merrill Lynch / ImClone Systems Inc. / Roth Capital Partners / McDonald Investments / Insider Trading / Inside Information 7 / Banc of America Securities LLC / /

Country

United States / /

Currency

USD / /

Event

Person Communication and Meetings / M&A / FDA Phase / Company Listing Change / /

IndustryTerm

law enforcement officers / telephone records / telephone conversation / treatment for irinotecan-refractory colorectal cancer / manipulative and deceptive devices / /

Organization

United States Securities and Exchange Commission / ImClone’s office of the General / National Association of Securities Dealers / Federal Bureau of Investigation / United States Food and Drug Administration / /

Person

Harlan Waksal / SAMUEL WAKSAL / MICHAEL S. SCHACHTER / CATHERINE M. FARMER / /

Position

Counsel / president / chief executive officer / and a director / Assistant United States Attorney Before / Magistrate Judge / representative / accountant / officer / executive vice-president / chief operating officer / and a director / Special Agent / /

Product

Erbitux / FDA / /

ProvinceOrState

Delaware / Florida / New York / Idaho / /

PublishedMedium

the BLA for FDA review / the FDA review / /

Technology

cellular telephone / /

SocialTag